Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atezolizumab and Bevacizumab in Hepatocellular Carcinoma”

87 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 87 results

Not applicableStudy completedNCT06416683
What this trial is testing

Atezolizumab and Bevacizumab Combination Recommended in a Multidisciplinary Consultation Meeting in Caen for Hepatocellular Carcinoma (ABCHCaen)

Who this might be right for
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
University Hospital, Caen 109
Early research (Phase 1)Active Not RecruitingNCT05097911
What this trial is testing

Phase I Study of RNA Oligonucleotide, MTL-CEBPA, Atezolizumab and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma.

Who this might be right for
Advanced Hepatocellular Carcinoma
National University Hospital, Singapore 33
Testing effectiveness (Phase 2)Ended earlyNCT04541173
What this trial is testing

Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Aiwu Ruth He, MD 6
Testing effectiveness (Phase 2)Study completedNCT05359861
What this trial is testing

Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Coherus Oncology, Inc. 30
Testing effectiveness (Phase 2)Looking for participantsNCT06819566
What this trial is testing

Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCC

Who this might be right for
Hepatocellular CarcinomaEsophageal VarixBleeding Esophageal Varices
Asan Medical Center 44
Large-scale testing (Phase 3)Study completedNCT03434379
What this trial is testing

Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 558
Large-scale testing (Phase 3)Study completedNCT05665348
What this trial is testing

Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy

Who this might be right for
HCC - Hepatocellular CarcinomaMetastatic CancerMetastatic Tumor
Federation Francophone de Cancerologie Digestive 229
Testing effectiveness (Phase 2)Looking for participantsNCT06294548
What this trial is testing

Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC

Who this might be right for
Hepatocellular Carcinoma
University of Alabama at Birmingham 45
Testing effectiveness (Phase 2)Looking for participantsNCT06789757
What this trial is testing

The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Inova Health Care Services 19
Early research (Phase 1)Active Not RecruitingNCT05546879
What this trial is testing

Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Grenoble 43
Not applicableNot Yet RecruitingNCT07824765
What this trial is testing

Heterogeneity of Treatment Effects of Adding Locoregional Therapies to Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma (ISMIO-026)

Who this might be right for
Unresectable Hepatocellular Carcinoma
Zhongda Hospital 2,658
Testing effectiveness (Phase 2)Study completedNCT04170556
What this trial is testing

Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)

Who this might be right for
Hepatocellular Carcinoma
Fundacion Clinic per a la Recerca Biomédica 69
Testing effectiveness (Phase 2)Ended earlyNCT05448677
What this trial is testing

Ezurpimtrostat Autophagy Inhibitor in Association With Atezolizumab-Bevacizumab in First Line Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Grenoble 3
Testing effectiveness (Phase 2)UnknownNCT05908916
What this trial is testing

Atezolizumab and Bevacizumab With Combined Radiotherapy for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Yonsei University 51
Not applicableUnknownNCT04730388
What this trial is testing

ATEZOLIZUMAB - BEVACIZUMAB in the Treatment Hepatocellular Carcinoma Inoperable or

Who this might be right for
Advanced Hepatocellular Carcinoma
University Hospital, Brest 100
Not applicableLooking for participantsNCT06323382
What this trial is testing

Locoregional Therapy Combined With Bevacizumab and PD1/L1 Inhibitor in Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular CarcinomaAnti-PD1/PDL1 AntibodyBevacizumab
Sun Yat-sen University 240
Early research (Phase 1)Looking for participantsNCT05096715
What this trial is testing

Atezolizumab+Bevacizumab+SBRT in Unresectable HCC

Who this might be right for
Unresectable Hepatocellular Carcinoma
Massachusetts General Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06133062
What this trial is testing

Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Chang Gung Memorial Hospital 45
Not applicableLooking for participantsNCT05763277
What this trial is testing

Ate-Bev Early Response Prediction Model in Advanced HCC

Who this might be right for
Hepatocellular CarcinomaAtezolizumab-bevacizumabResponse Evaluation
Seoul National University Hospital 170
Testing effectiveness (Phase 2)UnknownNCT05396937
What this trial is testing

Efficacy and Safety of T+A+RAD in HCC

Who this might be right for
Hepatocellular Carcinoma
Fudan University 42
Next Page